SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Strategic Trials to Define the Best Available Treatment for Neonatal and Pediatric Sepsis Caused by Carbapenem-resistant Organisms.

Donà, D; Sharland, M; Heath, PT; Folgori, L (2019) Strategic Trials to Define the Best Available Treatment for Neonatal and Pediatric Sepsis Caused by Carbapenem-resistant Organisms. Pediatr Infect Dis J, 38 (8). pp. 825-827. ISSN 1532-0987 https://doi.org/10.1097/INF.0000000000002381
SGUL Authors: Sharland, Michael Roy Heath, Paul Trafford Folgori, Laura

[img] PDF Accepted Version
Restricted to Repository staff only until 20 June 2020.
Available under License Creative Commons Attribution Non-commercial.

Download (825kB)

Abstract

The optimal standard of care for carbapenem-resistant bloodstream infections in children is currently unknown. This systematic review, aiming to define the best available treatments to be compared with new antibiotics in clinical trials, clearly points out the paucity of available data. The simplification and a wider harmonization of study design are a global priority to inform the best strategies to treat these life-threatening infections in children.

Item Type: Article
Additional Information: This is a non-final version of an article published in final form in Donà, D; Sharland, M; Heath, PT; Folgori, L (2019) Strategic Trials to Define the Best Available Treatment for Neonatal and Pediatric Sepsis Caused by Carbapenem-resistant Organisms. Pediatr Infect Dis J, 38 (8). pp. 825-827. ISSN 1532-0987 https://doi.org/10.1097/INF.0000000000002381
Keywords: 1114 Paediatrics And Reproductive Medicine, Pediatrics
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Pediatr Infect Dis J
ISSN: 1532-0987
Language: eng
Dates:
DateEvent
20 June 2019Published Online
19 April 2019Accepted
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
PubMed ID: 31261359
Go to PubMed abstract
URI: http://sgultest.da.ulcc.ac.uk/id/eprint/111019
Publisher's version: https://doi.org/10.1097/INF.0000000000002381

Actions (login required)

Edit Item Edit Item